21/12/2018

The national charity DEBRA announces it is funding a clinical trial to investigate the use of cannabinoid medicines to treat pain and itch in adults with Epidermolysis Bullosa (EB). EB is a potentially fatal skin condition which affects over 5,000 people in the UK. The biggest challenge for suffers of EB is living with the pain and itching caused by the condition. UK based charity DEBRA, the only national charity supporting people suffering from EB, is launching a patient driven…